- Associated Press - Friday, February 25, 2011

SEOUL, SOUTH KOREA (AP) - Samsung says it will form a joint venture with a U.S. company as the South Korean conglomerate expands further into biopharmaceuticals.

Samsung said in a release Friday that three of its group companies are partnering with clinical research company Quintiles Transnational Corp. of the United States in a venture with initial capital of 300 billion won ($266 million).

The Samsung companies, which include conglomerate flagship Samsung Electronics Co., will own 90 percent of the venture. Durham, North Carolina-based Quintiles will take 10 percent.

Samsung said that initial plans are for a factory to be constructed in South Korea that will produce biopharmaceutical drugs to treat cancer and arthritis.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide